Cargando…

Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor

Self-renewal of pluripotent mouse embryonic stem (ES) cells is sustained by the cytokine leukaemia inhibitory factor (LIF) acting through the transcription factor Stat3. Several targets of Stat3 have previously been identified, most notably the reprogramming factor Klf4. However, such factors are ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martello, Graziano, Bertone, Paul, Smith, Austin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Molecular Biology Organization 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791366/ https://www.ncbi.nlm.nih.gov/pubmed/23942233 http://dx.doi.org/10.1038/emboj.2013.177

Ejemplares similares

The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs
por: Zorzan, Irene, et al.
Publicado: (2020)

Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency
por: Carbognin, Elena, et al.
Publicado: (2016)

How Does Reprogramming to Pluripotency Affect Genomic Imprinting?
por: Perrera, Valentina, et al.
Publicado: (2019)

Rebuilding Pluripotency from Primordial Germ Cells
por: Leitch, Harry G., et al.
Publicado: (2013)

Leukaemia stem cells: hit or miss?
por: Glauche, I, et al.
Publicado: (2007)

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma
por: Buckley, Amy M., et al.
Publicado: (2018)

Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human
por: Takashima, Yasuhiro, et al.
Publicado: (2014)

Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human
por: Takashima, Yasuhiro, et al.
Publicado: (2015)

Epigenetic resetting of human pluripotency
por: Guo, Ge, et al.
Publicado: (2017)

Immunological Studies in Acute Myeloid Leukaemia: PHA Responsiveness and Serum Inhibitory Factors
por: Walker, J. S., et al.
Publicado: (1973)

Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics
por: Sart, Sebastien, et al.
Publicado: (2021)

Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis
por: Boroviak, Thorsten, et al.
Publicado: (2015)

YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer
por: Hergovich, Alexander
Publicado: (2012)

Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma
por: Di Giorgio, Cristina, et al.
Publicado: (2022)

Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass
por: Guo, Ge, et al.
Publicado: (2016)

COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)
por: Metcalfe, Su M.
Publicado: (2020)

CD133(+ )adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF)
por: Carter, Debra A, et al.
Publicado: (2009)

Requirement for STAT3 and its target, TFCP2L1, in self-renewal of naïve pluripotent stem cells in vivo and in vitro
por: Kraunsoe, Sophie, et al.
Publicado: (2023)

NANOG Amplifies STAT3 Activation and They Synergistically Induce the Naive Pluripotent Program
por: Stuart, Hannah T., et al.
Publicado: (2014)

Endometrial injury concurrent with hysteroscopy increases the expression of Leukaemia inhibitory factor: a preliminary study
por: Ersahin, Suat Suphan, et al.
Publicado: (2022)

Correction: Epigenetic resetting of human pluripotency (doi:10.1242/dev.146811)
por: Guo, Ge, et al.
Publicado: (2018)

Diazepam-induced loss of inhibitory synapses mediated by PLCδ/ Ca(2+)/calcineurin signalling downstream of GABAA receptors
por: Nicholson, Martin W., et al.
Publicado: (2018)

Leukaemia Inhibitory Factor Stimulates Proliferation of Olfactory Neuronal Progenitors via Inducible Nitric Oxide Synthase
por: Lopez-Arenas, Estefania, et al.
Publicado: (2012)

Research on the expression of integrin β3 and leukaemia inhibitory factor in the decidua of women with cesarean scar pregnancy
por: Qian, Zhi-Da, et al.
Publicado: (2017)

Capturing Pluripotency
por: Silva, Jose, et al.
Publicado: (2008)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Design principles of pluripotency
por: Smith, Austin
Publicado: (2009)

A common molecular logic determines embryonic stem cell self‐renewal and reprogramming
por: Dunn, Sara‐Jane, et al.
Publicado: (2018)

Acquisition and maintenance of pluripotency are influenced by fibroblast growth factor, leukemia inhibitory factor, and 2i in bovine-induced pluripotent stem cells
por: Botigelli, Ramon Cesar, et al.
Publicado: (2022)

Tracking the embryonic stem cell transition from ground state pluripotency
por: Kalkan, Tüzer, et al.
Publicado: (2017)

Inhibitory effect of YC8 leukaemia cell line on in vitro lymphocyte reactivity.
por: Biasi, G., et al.
Publicado: (1977)

Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
por: Rittchen, Sonja, et al.
Publicado: (2015)

Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link
por: Conroy, H., et al.
Publicado: (2010)

A method to identify and analyze biological programs through automated reasoning
por: Yordanov, Boyan, et al.
Publicado: (2016)

Leukæmia and Pseudo-Leukæmia
Publicado: (1877)

Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.
por: Rohatiner, A. Z.
Publicado: (1984)

Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
por: Hirose, M., et al.
Publicado: (1987)

LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth
por: Zhou, Jing, et al.
Publicado: (2011)

Identification of NRAS Downstream Genes with CRISPR Activation Screening
por: Tatsumi, Akiya, et al.
Publicado: (2022)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f65e71me84v0pe4n27hmpj8lqh